iRhythm Holdings, Inc.
About iRhythm Holdings, Inc.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $747.1M
- Net income
- -$44.6M
- Total assets
- $1.0B
- Market cap
- $3.6B
- Gross margin
- 70.6%
- Operating margin
- -7.7%
- Net margin
- -6.0%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $747.1M
- Cost of revenue
- $219.9M
- Gross profit
- $527.2M
- Operating expenses
- $584.7M
- Operating income
- -$57.4M
- Income tax
- $953.0K
- Net income
- -$44.6M
- EPS (basic)
- $-1.39
- EPS (diluted)
- $-1.39
Balance sheet
- Total assets
- $1.0B
- Current assets
- $702.8M
- Total liabilities
- $867.3M
- Current liabilities
- $151.9M
- Shareholders’ equity
- $152.7M
Cash flow
- Operating cash flow
- $80.9M
- Investing cash flow
- -$277.1M
- Financing cash flow
- $12.6M
- Net cash flow
- -$183.6M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $3.6B
- EPS (diluted)
- $-1.39
- Shares outstanding
- 33.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 20, 2016
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $44.6M in FY2025.
- Revenue grew 131% from FY2021 to FY2025.
- Gross margin of 70.6%, net margin -6.0%.
- Trading 43% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review iRhythm Holdings, Inc..
Write a review
News about iRhythm Holdings, Inc.
News & sentiment via Polygon.io
